Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Shuhei Hige"'
Autor:
Tomoaki Nakajima, Yoshiyasu Karino, Shuhei Hige, Hirokazu Suii, Ryoji Tatsumi, Masakatsu Yamaguchi, Tomohiro Arakawa, Yasuaki Kuwata, Joji Toyota
Publikováno v:
Annals of Hepatology, Vol 27, Iss 1, Pp 100566- (2022)
Introduction and objectives: Sustained virologic response (SVR) is achieved in most cases of C-type liver disease after direct-acting antiviral (DAA) therapy. Although liver fibrosis improves, the degree of improvement is different. This study aimed
Externí odkaz:
https://doaj.org/article/d659d04c2d2e4abe8c4707760d54fff6
Autor:
Hirokazu Suii, Itaru Ozeki, Ryoji Tatsumi, Masakatsu Yamaguchi, Mutsuumi Kimura, Tomohiro Arakawa, Tomoaki Nakajima, Yasuaki Kuwata, Takumi Ohmura, Shuhei Hige, Yoshiyasu Karino, Joji Toyota
Publikováno v:
Case Reports in Hepatology, Vol 2017 (2017)
Interferon (IFN) and ribavirin (RBV) combination therapy was previously the standard of care for treatment of hepatitis C virus (HCV) genotype 2 infection. But, it often induced hemolytic anemia. In 2014, sofosbuvir (SOF) was approved for the treatme
Externí odkaz:
https://doaj.org/article/23cfa00cf20f4f2f9b8d02ccaeb67c97
Autor:
Nao Nishida, Hiromi Sawai, Koichi Kashiwase, Mutsuhiko Minami, Masaya Sugiyama, Wai-Kay Seto, Man-Fung Yuen, Nawarat Posuwan, Yong Poovorawan, Sang Hoon Ahn, Kwang-Hyub Han, Kentaro Matsuura, Yasuhito Tanaka, Masayuki Kurosaki, Yasuhiro Asahina, Namiki Izumi, Jong-Hon Kang, Shuhei Hige, Tatsuya Ide, Kazuhide Yamamoto, Isao Sakaida, Yoshikazu Murawaki, Yoshito Itoh, Akihiro Tamori, Etsuro Orito, Yoichi Hiasa, Masao Honda, Shuichi Kaneko, Eiji Mita, Kazuyuki Suzuki, Keisuke Hino, Eiji Tanaka, Satoshi Mochida, Masaaki Watanabe, Yuichiro Eguchi, Naohiko Masaki, Kazumoto Murata, Masaaki Korenaga, Yoriko Mawatari, Jun Ohashi, Minae Kawashima, Katsushi Tokunaga, Masashi Mizokami
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e86449 (2014)
Previous studies have revealed the association between SNPs located on human leukocyte antigen (HLA) class II genes, including HLA-DP and HLA-DQ, and chronic hepatitis B virus (HBV) infection, mainly in Asian populations. HLA-DP alleles or haplotypes
Externí odkaz:
https://doaj.org/article/7d6ae97b78a745aa9f498075386541b3
Autor:
Nao Nishida, Hiromi Sawai, Kentaro Matsuura, Masaya Sugiyama, Sang Hoon Ahn, Jun Yong Park, Shuhei Hige, Jong-Hon Kang, Kazuyuki Suzuki, Masayuki Kurosaki, Yasuhiro Asahina, Satoshi Mochida, Masaaki Watanabe, Eiji Tanaka, Masao Honda, Shuichi Kaneko, Etsuro Orito, Yoshito Itoh, Eiji Mita, Akihiro Tamori, Yoshikazu Murawaki, Yoichi Hiasa, Isao Sakaida, Masaaki Korenaga, Keisuke Hino, Tatsuya Ide, Minae Kawashima, Yoriko Mawatari, Megumi Sageshima, Yuko Ogasawara, Asako Koike, Namiki Izumi, Kwang-Hyub Han, Yasuhito Tanaka, Katsushi Tokunaga, Masashi Mizokami
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e39175 (2012)
Hepatitis B virus (HBV) infection can lead to serious liver diseases, including liver cirrhosis (LC) and hepatocellular carcinoma (HCC); however, about 85-90% of infected individuals become inactive carriers with sustained biochemical remission and v
Externí odkaz:
https://doaj.org/article/59afb2a92ba448aaa14451fe64c81765
Autor:
Tatsunori Hanai, Hideto Kawaratani, Junji Nagano, Hirokazu Suii, Akira Sakamaki, Yoshitaka Arase, Hiroyuki Nakanishi, Tomomi Kogiso, Tomomi Okubo, Takao Miwa, Shogo Shimizu, Shuhei Hige, Masanori Atsukawa, Masahito Shimizu, Masayuki Kurosaki, Shuji Terai, Tatehiro Kagawa, Katsutoshi Tokushige, Hitoshi Yoshiji
Publikováno v:
Hepatology Research. 53:238-246
Cell-free and concentrated ascites reinfusion therapy (CART) and large-volume paracentesis (LVP) with albumin infusion are useful for managing refractory ascites (RA). However, it remains unclear which therapy is more effective in patients with cirrh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::372de97614603de8244e9d4fb12050a3
https://doi.org/10.1111/hepr.13860
https://doi.org/10.1111/hepr.13860
Autor:
Kazumasa, Sakamoto, Kiyoaki, Ito, Hiroshi, Yotsuyanagi, Hiroshi, Yatsuhashi, Yasuhito, Tanaka, Shuhei, Hige, Yasuhiro, Takikawa, Yoshiyuki, Ueno, Kazuhide, Yamamoto, Fumio, Imazeki, Jun, Inoue, Masayuki, Kurosaki, Takeji, Umemura, Hidenori, Toyoda, Eiji, Mita, Kojiro, Michitaka, Tatsuji, Maeshiro, Norie, Yamada, Atsushi, Suetsugu, Miwa, Kawanaka, Yuya, Seko, Kentaro, Matsuura, Akinori, Okumura, Yoshitaka, Fukuzawa, Masaya, Sugiyama, Masashi, Mizokami, Masashi, Yoneda
Publikováno v:
Journal of Gastroenterology. 57:971-980
Hepatitis B virus (HBV) is one of the most prevalent chronic viral infections that causes chronic hepatitis B (CHB). In Japan, genotypes B and C account for most of acute and chronic cases of hepatitis. However, previous studies showed that the preva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1da13a5d80a78aced953ef3c8f23a6fc
https://doi.org/10.1007/s00535-022-01921-4
https://doi.org/10.1007/s00535-022-01921-4
Autor:
Joji Toyota, Ryoji Tatsumi, Masakatsu Yamaguchi, Hirokazu Suii, Tomohiro Arakawa, Shuhei Hige, Yasuaki Kuwata, Tomoaki Nakajima
Publikováno v:
Internal Medicine
Objective This study evaluated the efficacy associated with switching to rifaximin in patients with hepatic cirrhosis receiving kanamycin sulfate for the treatment of hepatic encephalopathy and hyperammonemia. Methods We included 37 patients who swit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18dc9d082510685a55d45043acef8a7e
https://doi.org/10.2169/internalmedicine.6039-20
https://doi.org/10.2169/internalmedicine.6039-20
Autor:
Hideto Kawaratani, Yasuteru Kondo, Ryoji Tatsumi, Naoto Kawabe, Norikazu Tanabe, Akira Sakamaki, Kazuo Okumoto, Yoshihito Uchida, Kei Endo, Takumi Kawaguchi, Tsunekazu Oikawa, Yoji Ishizu, Shuhei Hige, Taro Takami, Shuji Terai, Yoshiyuki Ueno, Satoshi Mochida, Yasuhiro Takikawa, Takuji Torimura, Tomokazu Matsuura, Masatoshi Ishigami, Kazuhiko Koike, Hitoshi Yoshiji
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 6; Pages: 1571
Background: Rifaximin is commonly used for hepatic encephalopathy (HE). However, the effects of long-term treatment for Japanese people are limited. Therefore, this study aimed to investigate the effects and safety of long-term treatment with rifaxim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08f020c165ea094fcd548cab78eafb14
Autor:
Yoshiyasu Karino, Johannes Vermehren, Xiaoming Cheng, Marcus M. Mücke, Shuhei Hige, Hiroshi Aikata, Takuro Uchida, Anuj Gaggar, Stefan Zeuzem, Pei-Jer Chen, T. Jake Liang, Chun-Jen Liu, Nami Mori, Yuchen Xia, Mitsutaka Osawa, Yuji Teraoka, Kazuaki Chayama, Michio Imamura, Keiji Tsuji, Vithika Suri, Regina Umarova
Publikováno v:
J Clin Invest
In patients with HBV and HCV coinfection, HBV reactivation leading to severe hepatitis has been reported with the use of direct-acting antivirals (DAAs) to treat HCV infection. Here we studied the molecular mechanisms behind this viral interaction. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67f78ec098c6031e27ac7a3ef768b44b
https://doi.org/10.1172/jci135616
https://doi.org/10.1172/jci135616
Autor:
Tomohiro Arakawa, Hirokazu Suii, Joji Toyota, Shuhei Hige, Yasuaki Kuwata, Yoshiyasu Karino, Masakatsu Yamaguchi, Tomoaki Nakajima, Ryoji Tatsumi
Publikováno v:
Annals of Hepatology, Vol 27, Iss 1, Pp 100566-(2022)
Introduction and objectives: Sustained virologic response (SVR) is achieved in most cases of C-type liver disease after direct-acting antiviral (DAA) therapy. Although liver fibrosis improves, the degree of improvement is different. This study aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce98cea14a8c5704496a948201744986
http://www.sciencedirect.com/science/article/pii/S1665268121002659
http://www.sciencedirect.com/science/article/pii/S1665268121002659